Abstract:Objective:To evaluate the effect of transurethral resection of the prostate on nocturia and sleep quality in men with benign prostatic hyperplasia.Methods:This retrospective study included 122 patients who underwent TURP(transurethral resection of the prostate) for BPH(benign prostatic hyperplasia)from December 2016 to December 2018.The age was(69.7±7.9)years old. There was 20 cases with diabetes and 40 cases with hypertension. The preoperative mean prostate volume was (64.4±41.2)ml and mean BMI was (24.3±2.7)kg/m 2. The preoperative IPSS score was (20.5±5.5) points, the number of nocturia events(assessed by the seventh question of IPSS) was (4.4±1.9) times, hours of undisturbed sleep (HUS) was (1.7±1.0) h, 110 cases with HUS <3 h; nocturia quality-of-life questionnaire (N-QOL) was (24.9±6.3) points, quality of life (QOL) was (4.4±0.9) points. 111 patients had the urodynamic examination done. The maximum urine flow rate was (6.4±3.1) ml/s, the maximum bladder volume was (318.5±83.6) ml, the residual urine volume was (153.9±158.9) ml, and the maximum detrusor pressure was (78.4±35.5)cmH 2O.Detrusor muscle strength decreased in 27 cases, 18 cases had OAB, 9 cases of effective bladder capacity declined and 60 cases had bladder outlet obstruction. 42 cases had an effective bladder volume <200 ml, of which 33 had a maximum bladder capacity >200 ml with nocturia (4.5±1.9) times, 9 cases had a maximum bladder capacity ≤200 ml with nocturia (4.7±1.7) times. All 122 patients were treated with TURP. Result:122 patients were followed up for 3-20 months. After operation the number of nocturia significantly decreased to (1.9±1.23) times ( P<0.05), HUS significantly improved to(3.4±1.3) h ( P<0.05), and 91 cases had HUS ≥3 with 82.7% remission rate; N-QOL significantly improved to (37.3±6.7) points ( P<0.05), IPSS significantly decreased to (4.9±4.2) points ( P<0.05), and QOL significantly decreased (0.8±0.9) points ( P<0.05). 121 patients had nocturia ≥2 voids before surgery, and 96 patients had improved (≥50% reduction of nocturnal frequency). There were 68 patients with nocturia ≥2 voids after operation with total score of preoperative IPSS (21.8±5.3), and 54 patients with nocturia <2 voids with total score of preoperative IPSS (19.2±5.5)( P<0.05). Patients with a effective bladder capacity less than 200 ml were divided into a group with a maximum bladder volume ≤200 ml and a group with a maximum bladder capacity>200 ml. The nocturia did not improve significantly after surgery ( P>0.05) in the group with a maximum bladder volume ≤200 ml, and the nocturia in the group with a maximum bladder capacity >200 ml had significantly improvement ( P<0.05). The group with a maximum bladder capacity ≤200 ml had nocturia (3.4±1.5) times after surgery, which was no significant different from that before surgery ( P=0.12); nocturia (1.9±1.1) times after operation in the group with maximum bladder volume>200 ml, and there was significant difference compared with before surgery ( P<0.05). Conclusion:TURP can significantly prolong the HUS of BPH patients with nocturia, and improve the life and sleep quality of patients. TURP partly reduces the number of nocturia, but some patients still suffer from nocturia after operation. The high total score of IPSS before operation and the maximum bladder volume ≤200 ml are the risk factors for nocturia after operation.

Changes of Bladder Wall Thickness in Patients with Benign Prostatic Hyperplasia Before and after Operation

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

Changes of transforming growth factor-β of human detrusor after bladder outlet obstruction induced by benign prostatic hyperplasia

Changes of Basic Fibroblast Growth Factor in Bladder Smooth Muscle in Patients with Bladder Outlet Obstruction Induced by Benign Prostatic Hyperplasia

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

Clinical analysis and measures on voiding smoothly symptoms of patients following transurethral prostatic resection

[Changes of Urinary Symptoms after Transurethral Resection of the Prostate and Its Correlation with Clinical Parameters].

Effects of Bladder Neck Preservation and Anterior Urethral Wall Reconstruction on Early Urinary Control after Laparoscopic Radical Prostatectomy

Pre-and Post-Prostatectomy Detrusor Wall Thickness and the Symptom Profile in Patients with Benign Prostatic Enlargement: A Prospective Review

Analysis of Improved Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate

The effect of bladder function on the efficacy of transurethral prostatectomy in patients with benign prostatic hyperplasia: a retrospective, single-center study

Study on the relationship between chronic prostatitis and lower urinary tract symptoms and bladder neck contracture after transurethral resection of the prostate

Predictive Value Of Resistive Index, Detrusor Wall Thickness And Ultrasound Estimated Bladder Weight Regarding The Outcome After Transurethral Prostatectomy For Patients With Lower Urinary Tract Symptoms Suggestive Of Benign Prostatic Obstruction

Clinical experience of transurethral resection of prostate for voluminous benign prostatic hyperplasia

Multivariate Analysis On Improvement Of Nocturia In Patients With Benign Prostatic Hyperplasia After Transurethral Plasmakinetic Prostatectomy

Efficacy of Transurethral Resection of the Microscope over the Same Period of Benign Prostatic Hyperplasia and Bladder Stones

Application of Urethral Contrast Computed Tomography Three-Dimensional Imaging in the Postoperative Assessment of Prostate Hyperplasia

Effect of Transurethral Resection of the Prostate on Nocturia and Sleep Quality in Men with Benign Prostatic Hyperplasia

Analysis of Risk Factors Leading to Postoperative Urethral Stricture and Bladder Neck Contracture Following Transurethral Resection of Prostate

Comparison of Surgical Effect and Prognosis of Transurethral Resection and Open Surgery for Early Bladder Cancer

Improvement of Erectile Function in Patients with Benign Prostatic Hyperplasia Undergoing Transurethral Plasmakinetic Resection of the Prostate.